Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the blood pressure lowering effects of two different dosages of the
combination of olmesartan and hydrochlorothiazide in patients with moderate or severe high
blood pressure.
Phase:
Phase 3
Details
Lead Sponsor:
Daiichi Sankyo Inc. Daiichi Sankyo, Inc.
Collaborators:
Daiichi Sankyo Europe, GmbH Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company